US regulator says too many drugmakers chasing same cancer strategy - Reuters

US regulator says too many drugmakers chasing same cancer strategy Reuters CHICAGO, June 10 A new type of cancer drug that takes the brakes off the body's immune system has given drugmakers some remarkable wins against the deadly disease, but a top U.S. regulator says too many companies are focused on the same approach. and more »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNE-5hMnxNFGOU7On8C-OymTaHUgLQ&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779130905175&ei=OLpaV5DFA47Q3QHGwxE&url=http://www.reuters.com/article/health-cancer-fda-idUSL1N1911EM
via IFTTT